Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony S Basile

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Cellular and Molecular Neurobiology|April 26, 2006
Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677Piotr Popik, Martyna Krawczyk, Krystyna Golembiowska, et al.
Journal of Clinical Pharmacology|September 28, 2011
Population pharmacokinetics of pegaptanib in patients with neovascular, age-related macular degenerationAnthony S Basile, Matt Hutmacher, Dana Nickens, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 10, 2009
Preclinical evaluation of the abuse potential of the analgesic bicifadineKatherine L Nicholson, Robert L Balster, Krystyna Golembiowska, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 22, 2003
Vivitrex, an injectable, extended-release formulation of naltrexone, provides pharmacokinetic and pharmacodynamic evidence of efficacy for 1 month in ratsRaymond T Bartus, Dwaine F Emerich, Joyce Hotz, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 13, 2004
M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticityThomas Seeger, Irina Fedorova, Fang Zheng, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 24, 2014
Integrating disease progression models, non-clinical pharmacokinetic data and treatment response endpoints to optimize intravitreal dosing regimensAnthony S Basile, Theodore R Johnson, Karen J Klamerus, et al.
Journal of Neuroinflammation|August 3, 2004
Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptideSheng-Zhou Wu, Angela M Bodles, Mandy M Porter, et al.
Investigative Ophthalmology & Visual Science|January 25, 2014
RTP801 gene expression is differentially upregulated in retinopathy and is silenced by PF-04523655, a 19-Mer siRNA directed against RTP801Kay D Rittenhouse, Theodore R Johnson, Paolo Vicini, et al.
BMC Pharmacology|June 17, 2008
Pharmacological Properties of DOV 315,090, an ocinaplon metaboliteDmytro Berezhnoy, Maria C Gravielle, Scott Downing, et al.
Investigative Ophthalmology & Visual Science|July 28, 2011
Intravitreal concentrations of a near-infrared fluorescence-labeled biotherapeutic determined in situ using confocal scanning laser ophthalmoscopyAnthony S Basile, Genevieve Glazier, Alice Lee, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Cellular and Molecular Neurobiology|April 26, 2006
Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677Piotr Popik, Martyna Krawczyk, Krystyna Golembiowska, et al.
Journal of Clinical Pharmacology|September 28, 2011
Population pharmacokinetics of pegaptanib in patients with neovascular, age-related macular degenerationAnthony S Basile, Matt Hutmacher, Dana Nickens, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 10, 2009
Preclinical evaluation of the abuse potential of the analgesic bicifadineKatherine L Nicholson, Robert L Balster, Krystyna Golembiowska, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 22, 2003
Vivitrex, an injectable, extended-release formulation of naltrexone, provides pharmacokinetic and pharmacodynamic evidence of efficacy for 1 month in ratsRaymond T Bartus, Dwaine F Emerich, Joyce Hotz, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 13, 2004
M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticityThomas Seeger, Irina Fedorova, Fang Zheng, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 24, 2014
Integrating disease progression models, non-clinical pharmacokinetic data and treatment response endpoints to optimize intravitreal dosing regimensAnthony S Basile, Theodore R Johnson, Karen J Klamerus, et al.
Journal of Neuroinflammation|August 3, 2004
Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptideSheng-Zhou Wu, Angela M Bodles, Mandy M Porter, et al.
Investigative Ophthalmology & Visual Science|January 25, 2014
RTP801 gene expression is differentially upregulated in retinopathy and is silenced by PF-04523655, a 19-Mer siRNA directed against RTP801Kay D Rittenhouse, Theodore R Johnson, Paolo Vicini, et al.
BMC Pharmacology|June 17, 2008
Pharmacological Properties of DOV 315,090, an ocinaplon metaboliteDmytro Berezhnoy, Maria C Gravielle, Scott Downing, et al.
Investigative Ophthalmology & Visual Science|July 28, 2011
Intravitreal concentrations of a near-infrared fluorescence-labeled biotherapeutic determined in situ using confocal scanning laser ophthalmoscopyAnthony S Basile, Genevieve Glazier, Alice Lee, et al.
Pageof 4